Practicalities and risks of biopsy

Date 08 October 2016
Event ESMO 2016 Congress
Session Definition and management of oligoprogression during treatment with TKI inhibitors
Topics Non-Small-Cell Lung Cancer, Metastatic
Presenter Josephine Barry
Authors J.E. Barry
  • Department Of Imaging, Cork University Hospital, n/a - Cork/IE